Cancer Genetics and Epigenetics 2024, Vol.12, No.5, 279-293 http://medscipublisher.com/index.php/cge 287 8 Challenges and Ethical Issues in Genetic Diagnosis 8.1 Sensitivity, Specificity, and Technical Limitations of Genetic Testing Genetic testing for breast cancer has significantly advanced, offering precise diagnostic and prognostic capabilities. However, these tests face challenges related to sensitivity and specificity. For instance, while multigene assays (MGAs) can predict prognosis and guide treatment in early-stage breast cancer, their accuracy can be compromised by the heterogeneity of the disease. This heterogeneity means that not all genetic mutations are detected, potentially leading to false negatives or positives, which can affect treatment decisions and patient outcomes (Zubair et al., 2021; Yang et al., 2023). Additionally, the detection of circulating tumor DNA (ctDNA) in blood samples, although promising, is limited by the small quantities of DNA shed by early-stage tumors, making it difficult to achieve high sensitivity and specificity (Phallen et al., 2017; Zhang et al., 2019). Technical limitations also pose significant challenges. Advanced techniques like targeted error correction sequencing (TEC-Seq) have been developed to improve the detection of genetic changes in ctDNA, but these methods require sophisticated equipment and expertise, which may not be widely available (Phallen et al., 2017). Moreover, the integration of genetic testing with traditional diagnostic methods, such as imaging and biopsy, is still evolving, and discrepancies between different diagnostic tools can lead to inconsistent results (Wang, 2017; Zubair et al., 2021). These technical challenges highlight the need for continuous improvement and validation of genetic testing methods to ensure their reliability and accuracy in clinical practice. 8.2 Discussion of privacy and ethical concerns regarding genetic data The use of genetic testing in breast cancer diagnosis raises significant privacy and ethical concerns. Genetic data is highly sensitive and personal, and its misuse can lead to discrimination and stigmatization. For example, individuals with a genetic predisposition to breast cancer may face discrimination in employment or insurance if their genetic information is not adequately protected (Silva et al., 2019; Lebeau et al., 2023). Ensuring the confidentiality of genetic data is crucial, and robust legal and ethical frameworks are needed to safeguard patients' privacy. Ethical concerns also arise regarding informed consent and the potential psychological impact of genetic testing. Patients must be fully informed about the implications of genetic testing, including the possibility of discovering incidental findings that may not be related to breast cancer but could have significant health implications (Silva et al., 2019). Additionally, the psychological burden of knowing one's genetic risk for breast cancer can be substantial, leading to anxiety and stress. Healthcare providers must be prepared to offer appropriate counseling and support to help patients cope with the emotional and psychological challenges associated with genetic testing (Ginsburg et al., 2020; Lebeau et al., 2023). 8.3 Social equity issues in the widespread application of genetic diagnostic technologies The widespread application of genetic diagnostic technologies for breast cancer detection is fraught with social equity issues. Access to these advanced diagnostic tools is often limited by socioeconomic factors, with disadvantaged populations facing significant barriers to obtaining timely and accurate genetic testing. For instance, individuals from lower socioeconomic backgrounds may lack access to healthcare facilities that offer genetic testing, or they may be unable to afford the costs associated with these tests (Ginsburg et al., 2020; Lebeau et al., 2023). This disparity can lead to delayed diagnoses and poorer outcomes for these populations. Moreover, the implementation of genetic testing must consider the diversity of the population. Many genetic studies have historically focused on populations of European descent, potentially limiting the applicability of genetic tests to other ethnic groups. Ensuring that genetic research includes diverse populations is essential to developing diagnostic tools that are effective for all demographic groups (Lebeau et al., 2023). Efforts to address these social equity issues include increasing the diversity of research study populations and developing policies that ensure equitable access to genetic testing and related healthcare services (Ginsburg et al., 2020; Lebeau et al., 2023). These measures are crucial for ensuring that the benefits of genetic diagnostic technologies are accessible to all individuals, regardless of their socioeconomic status or ethnic background.
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==